Related references
Note: Only part of the references are listed.The Expression of Claudin-1, Claudin-2, Claudin-3, and Claudin-4 in Gastric Cancer Tissue
Hun Jung et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
Naru Kondo et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin
Hideki Kakutani et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma
Chuen Hsueh et al.
HUMAN PATHOLOGY (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers
Masayo Suzuki et al.
CANCER SCIENCE (2009)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
Amanda Blackford et al.
CLINICAL CANCER RESEARCH (2009)
Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival
Satoshi Ohtani et al.
GASTRIC CANCER (2009)
S100A4 mRNA is a Diagnostic and Prognostic Marker in Pancreatic Carcinoma
Naoki Ikenaga et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas
Michael W. Mueller et al.
AMERICAN JOURNAL OF SURGERY (2008)
High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF
Andreas-Claudius Hoffmann et al.
NEOPLASIA (2008)
The claudin gene family: expression in normal and neoplastic tissues
Kyle J. Hewitt et al.
BMC CANCER (2006)
One thousand consecutive pancreaticoduodenectomies
JL Cameron et al.
ANNALS OF SURGERY (2006)
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine
E Giovannetti et al.
CANCER RESEARCH (2006)
Molecular prognostic markers in pancreatic cancer: A systematic review
G Garcea et al.
EUROPEAN JOURNAL OF CANCER (2005)
Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization
J Antonov et al.
LABORATORY INVESTIGATION (2005)
Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer
K Ohuchida et al.
CLINICAL CANCER RESEARCH (2005)
Does anyone survive pancreatic ductal adenocarcinoma?: A nationwide study re-evaluating the data of the Finnish Cancer Registry
M Carpelan-Holmström et al.
GUT (2005)
Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4
SL Kominsky et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: Increased expression of matrix metalloproteinase-7 predicts poor survival
LE Jones et al.
CLINICAL CANCER RESEARCH (2004)
Curative resection is the single most important factor determing outcome in patients with pancreatic adenocarcinoma
M Wagner et al.
BRITISH JOURNAL OF SURGERY (2004)
Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions
K Ohuchida et al.
CANCER RESEARCH (2004)
Expressions of angiogenic factors in pancreatic ductal carcinoma: A correlative study with clinicopathologic parameters and patient survival
K Kuwahara et al.
PANCREAS (2003)
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays
CA Iacobuzio-Donahue et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction - A methodological study on lymph nodes from melanoma patients
HN Abrahamsen et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2003)
Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells
TA Martin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas
M Niedergethmann et al.
PANCREAS (2002)
p16(INK4a) is a prognostic marker in resected ductal pancreatic cancer - An analysis of p16(INK4a), p53, MDM2, an Rb
B Gerdes et al.
ANNALS OF SURGERY (2002)
Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma
YE Joo et al.
PANCREATOLOGY (2002)
Claudin-4:: A new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin
P Michl et al.
GASTROENTEROLOGY (2001)
Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: Effects on clinical outcome and efficacy of adjuvant chemotherapy
Y Nio et al.
JOURNAL OF SURGICAL ONCOLOGY (2001)
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: Clinicopathologic and prognostic significance of matrilysin expression
H Yamamoto et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Na,K-ATPase β-subunit is required for epithelial polarization, suppression of invasion, and cell motility
SA Rajasekaran et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Claudins regulate the intestinal barrier in response to immune mediators
T Kinugasa et al.
GASTROENTEROLOGY (2000)